Replies to post #10120 on Lexington Biosciences Inc. (LXGTF)

[5bjjamie5]

The Vendys is for offices use only. Heart Sentry can be used in offices AND the general public thereby attracting Fitbit, etc...

[5bjjamie5]

The Endopat cost per unit is $5,500-$6,500. More importantly per fda.gov:

“The device is intended to be used in a hospital or clinic environment by competent health professionals...
The Endo PAT 2000 device is not intended for use as a screening test in the general patient population.”

There’s your answer!!

[5bjjamie5]

I just saw on slideshare.net that the cost is $34,000 WOW!! Restricted use by professionals only and a high price tag? Look out, Endo, here comes Lex!!!

[gopherdat]

I think the Endopat will be replaced by the heart sentry. I watched the presentation (Endopat's) and I believe the Heart Sentry will not only be more accurate (via different test area and test methods)but will be much more operator friendly and more cost effective in not only equipment cost, but in the training of technicians to operate the device. I also believe the Heart Sentry will become the next device in a home health monitoring system whereas the Endopat's complicated testing method will not be consumer friendly therefore limiting it to physicians. (Not to mention that the accuracy be limited to operator controls therefore less consistent results)
The Heart Sentry will be lower cost, easier to operate, while in my opinion due to method of detection, more accurate.